Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymphoseek for lymph node detection in anal cancer
NCT02857608Phase 2Withdrawn
- Sponsor
- Cardinal Health
- Start
- Sep 2016
- Primary completion
- Aug 2017
- Modality
- Radiopharmaceutical, Biologic
01
Overview
A Phase 2 trial of technetium tc 99m tilmanocept in anal squamous cell carcinoma (SCCA), sponsored by Cardinal Health. Planned start Sep 2016; status: withdrawn.
02
Drugs
technetium tc 99m tilmanocept
03
Conditions
anal squamous cell carcinoma (SCCA)
Beyond the preview
Go deeper on NCT02857608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02857608.